Erdosteine
Product Specifications
UNSPSC Description
Erdosteine inhibits lipopolysaccharide (LPS)-induced NF-κB activation[1][2]. Erdosteine has muco-modulatory, anti-bacterial, anti-inflammatory and anti-oxidant effects[3].
Target Antigen
Bacterial; NF-κB
Type
Reference compound
Related Pathways
Anti-infection;NF-κB
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Infection; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Erdosteine.html
Purity
99.83
Solubility
DMSO : 50 mg/mL (ultrasonic)|H2O : 6.67 mg/mL (ultrasonic)
Smiles
O=C(O)CSCC(NC(CCS1)C1=O)=O
Molecular Weight
249.31
References & Citations
[1]Park JS, et al. Anti-inflammatory Effect of Erdosteine in Lipopolysaccharide-Stimulated RAW 264.7 Cells. Inflammation. 2016 Aug;39(4):1573-81.|[2]Oktar S, et al. Beneficial effect of erdosteine on methotrexate-induced testicular toxicity in mice. Toxicol Ind Health. 2010 Aug;26(7):433-8.|[3]Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B0289/Erdosteine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B0289/Erdosteine-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
84611-23-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6282449-01 0.1 mL
CCNH, CT (CCNH, Cyclin-H, MO15-associated protein, p34, p37) (MaxLight 490)
Ask
View Details 
MBS6282449-02 5x 0.1 mL
CCNH, CT (CCNH, Cyclin-H, MO15-associated protein, p34, p37) (MaxLight 490)
Ask
View Details